
November 20, 2026
A strong Sharpe ratio can attract an institutional investor's attention. A convincing backtest can open the door to a meeting. But neither guarantees an allocation.
Institutional investors need to understand whether a quantitative strategy is reliable, scalable, and suitable for their portfolios. Their due diligence goes beyond historical returns to examine the investment process, risk controls, operational infrastructure, and people responsible for managing capital.
So, what questions should quant managers be ready to answer?
One of the first questions institutional investors ask is what drives a strategy's returns. A manager might demonstrate impressive performance, but investors need to understand the economic or behavioral rationale behind it.
They want to know whether the strategy exploits a persistent market inefficiency, relies on temporary conditions, or benefits from exposures that could disappear. A convincing explanation should connect the underlying hypothesis to the strategy's actual trading behavior.
Questions investors ask:
Managers who can explain their investment logic clearly are better positioned to demonstrate that their results reflect a repeatable process.
Backtested performance is useful, but institutional investors distinguish between simulated results and returns generated with real capital. They examine the methodology, assumptions, and consistency of the reported numbers.
Transaction costs, slippage, survivorship bias, and overfitting can significantly affect simulated performance. Investors also want to understand whether a strategy has changed since its original development and how those changes influenced results.
Questions investors ask:
Transparent performance reporting allows investors to assess the strength of the evidence supporting a manager's claims.
Institutional investors are interested in downside risk as much as potential returns. A strategy that performs well in favorable conditions may behave very differently during periods of market stress.
Allocators examine drawdowns, leverage, concentration, and exposure to different risk factors. They also want to understand how risk limits operate in practice and whether managers can intervene when automated systems behave unexpectedly.
Questions investors ask:
Documented risk procedures, stress testing, and evidence of effective controls can help investors assess whether a manager is prepared for adverse conditions.
A profitable strategy at $10 million in assets may produce very different results at $500 million. Institutional investors therefore examine strategy capacity before committing substantial capital.
Capacity depends on market liquidity, trading frequency, position sizes, execution costs, and the strategy's market impact. As assets grow, these constraints can reduce expected returns or require changes to the investment process.
Questions investors ask:
Managers should support capacity estimates with realistic assumptions and explain how they monitor changes as assets under management increase.
A strategy can deliver attractive standalone returns without improving an institutional portfolio. Investors evaluate how a potential allocation interacts with their existing exposures and investment objectives.
Correlation, factor sensitivity, volatility, and performance during market stress all influence this assessment. A strategy that provides genuine diversification may be particularly valuable even if its standalone returns are less impressive than those of competing managers.
Questions investors ask:
Managers who understand portfolio-level considerations can communicate their investment proposition more effectively.
Investment performance represents only one part of institutional due diligence. Investors also evaluate the operational infrastructure supporting the strategy.
This includes trading systems, cybersecurity, compliance, valuation, service providers, and business continuity arrangements. Institutional investors need confidence that the organization can manage capital responsibly, maintain accurate records, and respond to operational failures.
Questions investors ask:
Even smaller managers can demonstrate institutional readiness through documented procedures, appropriate oversight, and reliable external partners.
Quantitative strategies depend on technology, but people remain responsible for research, implementation, and oversight. Institutional investors assess the experience, responsibilities, and stability of the investment team.
Key-person risk can be particularly important for emerging managers whose research and trading infrastructure depend heavily on a small number of individuals. Investors want to know whether the strategy can continue operating if a critical team member leaves.
Questions investors ask:
Clear governance and well-defined responsibilities help demonstrate that the investment process can remain consistent over time.
Institutional due diligence is an ongoing process rather than a single meeting or questionnaire. Managers should prepare consistent, evidence-based answers and maintain documentation that can withstand independent review.
A practical preparation checklist includes:
These materials help investors evaluate a strategy efficiently and identify areas requiring further investigation.
Institutional investors are ultimately trying to determine whether a quantitative strategy can deliver its intended results within an acceptable risk and operational framework.
Strong performance may generate initial interest, but transparent reporting, credible risk management, realistic capacity estimates, and reliable operations are essential to a successful due diligence process.
For quant managers seeking institutional capital, preparation begins long before the first investor meeting. The ability to explain and substantiate every important aspect of a strategy can make the difference between attracting attention and progressing toward an allocation.